Intro

This chapter introduces a new podcast series dedicated to discussing recent medical studies, starting with the ESSENCE trial on semaglutide for treating fatty liver disease. It highlights the growing prevalence of metabolic dysfunction-associated steatohepatitis and the breakthrough findings that could enhance treatment options.